ECOG (click for all protocols, scroll to the appropriate protocol)
A Phase II Randomized Trial of Doxetaxel Based Induction Chemotherapy in Patients with N2/N3 Locally Advanced Head and Neck Cancer.
PI:George Adams, M.D.
Contact Number: Katie Cole, R.N. 612-625-5602